The Neurodevelopmental and Behavioral Phenotyping Screening Protocol

StatusRecruiting
PhaseNot specified
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

The 50 most recent of 383 record versions are accounted for below. See every version on ClinicalTrials.gov ↗

  1. New version filed on ClinicalTrials.gov
  2. 35 versions Re-verified since May 13, 2025, no change to tracked fieldsv348-v382
  3. Study Status, Study Description, Contacts/Locationsv347
  4. 13 versions Re-verified since Oct 26, 2024, no change to tracked fieldsv334-v346
The purpose of this protocol is to allow for the careful evaluation of healthy volunteers and individuals with risk for psychiatric disorders or neurodevelopmental disorders, such as autism spectrum disorder for specific protocols at NIH.
Trial Details
NCT Number NCT00271622
Lead Sponsor National Institute of Mental Health (NIMH)
Conditions
(from sponsor)		 Neurologic Disorders, Autism, Neurodegenerative Disease, Neurobehavioral Manifestation
Related terms Autism Spectrum Disorder, Autistic Disorder, Child Development Disorders, Pervasive, Learning Disabilities, Nervous System Diseases, Neurobehavioral Manifestations, Neurodegenerative Diseases
Enrollment 5,000 participants
Start Date
Updated on ClinicalTrials.gov